Conduit Pharmaceuticals Inc
NASDAQ:CDT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rain Industries Ltd
BSE:500339
|
IN |
|
H
|
Hwa Create Corp
SZSE:300045
|
CN |
|
V
|
Vision International Holdings Ltd
HKEX:8107
|
HK |
|
G
|
Global Petroleum Ltd
LSE:GBP
|
AU |
|
Playfair Mining Ltd
XTSX:PLY
|
CA |
|
Natwest Group PLC
LSE:NWG
|
UK |
|
Odawara Engineering Co Ltd
TSE:6149
|
JP |
|
MRC Global Inc
NYSE:MRC
|
US |
|
S
|
Sundiro Holding Co Ltd
SZSE:000571
|
CN |
|
J
|
J-Max Co Ltd
TSE:3422
|
JP |
|
A
|
Applied Nutrition PLC
LSE:APN
|
UK |
During the last 3 months Conduit Pharmaceuticals Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 135% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/cdt/vs/indx/gspc">open performance analysis).
The last transaction was made on Oct 7, 2024 by Nirland Ltd , who sold 96.5k USD worth of CDT shares.
During the last 3 months Conduit Pharmaceuticals Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 135% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/cdt/vs/indx/gspc">open performance analysis).
The last transaction was made on Oct 7, 2024 by Nirland Ltd , who sold 96.5k USD worth of CDT shares.
Conduit Pharmaceuticals Inc
Glance View
Conduit Pharmaceuticals Inc is a US-based company operating in industry. The company is headquartered in San Diego, California. The company went IPO on 2022-02-03. Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The firm is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto’s Thyroiditis. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. The company is used as a treatment option for Hashimoto’s Thyroiditis (HT) and Graves’ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto’s Thyroiditis and Graves’ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.